22nd Century Group Inc
XXII
Company Profile
Business description
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.
Contact
321 Farmington Road
MocksvilleNC27028
USAT: +1 336 940-3769
Sector
Consumer Defensive
Stock type
Defensive
Industry
Tobacco
Fiscal Year End
31 December 2025
Employees
56
Stocks News & Analysis
stocks
Nvidia: Collaboration with Intel might bring some goodwill with the US
We doubt the $5 billion is meaningful enough to force Nvidia to use Intel, either for core products or even for the chips in collaboration.
stocks
What now for Santos after takeover offer collapses?
Our Fair Value estimate once again reflects the stand-alone business and its growth potential.
stocks
Morningstar initiates coverage on small cap ASX REIT
Coverage of ASX listed REIT as investor interest in property continues to grow.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,061.20 | 61.30 | -0.67% |
CAC 40 | 7,853.59 | 1.02 | -0.01% |
DAX 40 | 23,639.41 | 35.12 | -0.15% |
Dow JONES (US) | 46,315.27 | 172.85 | 0.37% |
FTSE 100 | 9,216.67 | 11.44 | -0.12% |
HKSE | 26,545.10 | 106.59 | 0.40% |
NASDAQ | 22,631.48 | 160.75 | 0.72% |
Nikkei 225 | 45,045.81 | 143.54 | 0.32% |
NZX 50 Index | 13,231.66 | 3.23 | -0.02% |
S&P 500 | 6,664.36 | 32.40 | 0.49% |
S&P/ASX 200 | 8,773.50 | 75.00 | -0.85% |
SSE Composite Index | 3,820.09 | 11.57 | -0.30% |